Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723517 | SCV000112094 | uncertain significance | not provided | 2016-06-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723517 | SCV000534562 | benign | not provided | 2020-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000263883 | SCV001014837 | likely benign | Kabuki syndrome | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000723517 | SCV004130783 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | KMT2D: BS1, BS2 |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000723517 | SCV001953708 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000723517 | SCV001964470 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004542770 | SCV004783967 | benign | KMT2D-related disorder | 2019-08-27 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |